These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22716143)

  • 1. Potential protective effects of cannabidiol on neuroanatomical alterations in cannabis users and psychosis: a critical review.
    Hermann D; Schneider M
    Curr Pharm Des; 2012; 18(32):4897-905. PubMed ID: 22716143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The yin and yang of cannabis-induced psychosis: the actions of Δ(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia.
    Arnold JC; Boucher AA; Karl T
    Curr Pharm Des; 2012; 18(32):5113-30. PubMed ID: 22716133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol.
    Demirakca T; Sartorius A; Ende G; Meyer N; Welzel H; Skopp G; Mann K; Hermann D
    Drug Alcohol Depend; 2011 Apr; 114(2-3):242-5. PubMed ID: 21050680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical use of cannabis. Cannabidiol: a new light for schizophrenia?
    Deiana S
    Drug Test Anal; 2013 Jan; 5(1):46-51. PubMed ID: 23109356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis.
    Hahn B
    Schizophr Bull; 2018 Jan; 44(1):46-53. PubMed ID: 29083450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis-associated psychosis: Neural substrate and clinical impact.
    Murray RM; Englund A; Abi-Dargham A; Lewis DA; Di Forti M; Davies C; Sherif M; McGuire P; D'Souza DC
    Neuropharmacology; 2017 Sep; 124():89-104. PubMed ID: 28634109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective and physiological effects of oromucosal sprays containing cannabinoids (nabiximols): potentials and limitations for psychosis research.
    Schoedel KA; Harrison SJ
    Curr Pharm Des; 2012; 18(32):5008-14. PubMed ID: 22716155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Does cannabis use lead to schizophrenia?].
    Heekeren K
    Praxis (Bern 1994); 2011 Nov; 100(22):1361-7. PubMed ID: 22048912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of the antipsychotic properties of cannabidiol in humans.
    Iseger TA; Bossong MG
    Schizophr Res; 2015 Mar; 162(1-3):153-61. PubMed ID: 25667194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis.
    Morgan CJ; Curran HV
    Br J Psychiatry; 2008 Apr; 192(4):306-7. PubMed ID: 18378995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studies.
    Rapp C; Bugra H; Riecher-Rössler A; Tamagni C; Borgwardt S
    Curr Pharm Des; 2012; 18(32):5070-80. PubMed ID: 22716152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cannabis use in subjects at ultra high risk for psychosis].
    Fekih-Romdhane F; Hakiri A; Fadhel SB; Cheour M
    Presse Med; 2019 Nov; 48(11 Pt 1):1229-1236. PubMed ID: 31732360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study.
    Delvecchio G; Oldani L; Mandolini GM; Pigoni A; Ciappolino V; Schiena G; Lazzaretti M; Caletti E; Barbieri V; Cinnante C; Triulzi F; Brambilla P
    J Vis Exp; 2020 Aug; (162):. PubMed ID: 32894263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cannabis and psychoses].
    Kristensen FW
    Ugeskr Laeger; 1994 May; 156(19):2875-8, 2881. PubMed ID: 8009723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol.
    Gomes FV; Llorente R; Del Bel EA; Viveros MP; López-Gallardo M; Guimarães FS
    Schizophr Res; 2015 May; 164(1-3):155-63. PubMed ID: 25680767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity.
    Juckel G; Roser P; Nadulski T; Stadelmann AM; Gallinat J
    Schizophr Res; 2007 Dec; 97(1-3):109-17. PubMed ID: 17884351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.
    Fasinu PS; Phillips S; ElSohly MA; Walker LA
    Pharmacotherapy; 2016 Jul; 36(7):781-96. PubMed ID: 27285147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors.
    Pazos MR; Mohammed N; Lafuente H; Santos M; Martínez-Pinilla E; Moreno E; Valdizan E; Romero J; Pazos A; Franco R; Hillard CJ; Alvarez FJ; Martínez-Orgado J
    Neuropharmacology; 2013 Aug; 71():282-91. PubMed ID: 23587650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
    van Amsterdam J; Brunt T; van den Brink W
    J Psychopharmacol; 2015 Mar; 29(3):254-63. PubMed ID: 25586398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.